Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Announcement Summary

For personal use only

Entity name

MEDIBIO LIMITED

Date of this announcement

Tuesday January 18, 2022

The +securities the subject of this notification are:

Other

Total number of +securities to be issued/transferred

Total number of

ASX +security

+securities to be

code

Security description

issued/transferred

Issue date

MEBAD

OPTION EXPIRING VARIOUS DATES EX

2,000,000

18/01/2022

VARIOUS PRICES

Refer to next page for full details of the announcement

Notification of Issue, Conversion or Payment up of Unquoted

1 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 1 - Entity and announcement details

For personal use only

1.1 Name of entity

MEDIBIO LIMITED

We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.

1.2

Registered number type

Registration number

ABN

58008130336

1.3

ASX issuer code

MEB

  1. The announcement is New announcement
  2. Date of this announcement

18/1/2022

Notification of Issue, Conversion or Payment up of Unquoted

2 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 2 - Issue details

For personal use only

2.1 The +securities the subject of this notification are: Other

Please specify

Unlisted options granted to members of the Company's Growth & Advocacy Advisory Board as fees.

2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:

has an existing ASX security code ("existing class")

Notification of Issue, Conversion or Payment up of Unquoted

3 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 3B - number and type of +securities the subject of this notification (existing class) where issue has not previously been notified to

ASX in an Appendix 3B

For personal use only

Additional +securities in an existing class

ASX +security code and description

MEBAD : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

Date the +securities the subject of this notification were issued

18/1/2022

Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class

Yes

Any other information the entity wishes to provide about the +securities the subject of this notification

Unlisted options granted to members of the Company's Growth & Advocacy Advisory Board (GAAB) as fees for participation in the GAAB.

Please provide any further information needed to understand the circumstances in which you are notifying the issue of these +securities to ASX, including why the issue of the +securities has not been previously announced to the market in an Appendix 3B

N/A

Notification of Issue, Conversion or Payment up of Unquoted

4 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Issue details

For personal use only

Number of +securities

2,000,000

Were the +securities issued for a cash consideration?

No

Please describe the consideration being provided for the +securities

The securities are being issued as fees for services provided in relation to the GAAB.

Purpose of the issue

To pay for services rendered

Additional Details

The Option have an exercise price of $0.01 (1 cent) per option and will expire on 1 October 2025.

Notification of Issue, Conversion or Payment up of Unquoted

5 / 7

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Medibio Limited published this content on 18 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 January 2022 03:14:04 UTC.